Article Text
PDF
Abstract
Mucopolysaccharidosis VI is an autosomal recessive lysosomal storage disorder associated with severe disability and premature death. The presence of a mucopolysaccharidosis-like disease in indigenous ethnic groups in Colombia can be inferred from archaeological findings. There are several indigenous patients with mucopolysaccharidosis VI currently receiving enzyme replacement therapy. We discuss the ethical and economic considerations, regarding both direct and indirect costs, of a high-cost orphan disease in a marginalised minority population in a developing country.
- Research on special populations
- social aspects
- clinical ethics
- cultural pluralism
- health economics
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
Statistics from Altmetric.com
Footnotes
Funding This study was supported by Biomarin Colombia.
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.
Linked Articles
- The concise argument
Other content recommended for you
- Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis
- Cardiac issues in adults with the mucopolysaccharidoses: current knowledge and emerging needs
- Progression of eye disease over 15 years in a patient with mucopolysaccharidosis type VI on enzyme replacement therapy
- Screening patients referred to a metabolic clinic for lysosomal storage disorders
- Musculoskeletal manifestations of lysosomal storage disorders
- Bio-Plex immunoassay measuring the quantity of lysosomal N-acetylgalactosamine-6-sulfatase protein in dried blood spots for the screening of mucopolysaccharidosis IVA in newborn: a pilot study
- ‘Doctor Google’ ending the diagnostic odyssey in lysosomal storage disorders: parents using internet search engines as an efficient diagnostic strategy in rare diseases
- Clinical and morphological features including expression of βig-h3 and keratan sulphate proteoglycans in Maroteaux-Lamy syndrome type B and in normal cornea
- Clinical course of sly syndrome (mucopolysaccharidosis type VII)
- Avoiding diagnostic delay for mucopolysaccharidosis IIIB: do not overlook common clues such as wheezing and otitis media